Darst SA / Gibson AE / Goodrich / G2 / E Laboratory / HP / McCormick / Garrett / Suzuki / /
Country
United Kingdom / / /
Event
Product Issues / FDA Phase / /
Facility
A-Cdk2 complex / UT E Laboratory of Molecular Biophysics / University of Oxford / Laboratory of Molecular Biophysics / CAK complex / / /
IndustryTerm
natural product / chemical libraries / cancer therapy / xeroderma pigmentosum disorder / recognition site / interaction site / phosphorylation site / catalytic site / transcriptional machinery / treatment for cancer / /
MedicalCondition
experimental mesangial proliferative glomerulonephritis / JE / HIV / rat tumor / human tumor / heart disease / Hepatitis C / hepatitis B / J Cancer / colon carcinoma HT29 / Hayashi N. Hepatitis C / squamous cell carcinomas / MS / human breast cancer / xeroderma pigmentosum disorder / lymphoma xenografts / dissociation / tumor / advanced gastric carcinoma / cancer / human leukemia / In tumor / tumour / HCV / viral infections / diseases / cervical carcinomas / herpes simplex virus / prostate carcinoma / tumours / /
MedicalTreatment
cancer therapy / immunosuppression / /
MusicGroup
Blood / /
Organization
LA ND / First CDK2 association / Laboratory of Molecular Biophysics / University of Oxford / Department of Biochemistry / Association of Cdk-activating / /
Person
Louise N. Johnson / Laurence V / James SR / Hunt T. Cell / Grant S. Cyclin-dependent / Graziano Lolli / / /
Position
Archer / Harper / Naven RT / Cao / Major / Fisher / /
Product
TC / RL / CYC202 / RNA polymerase / /
RadioStation
Thunnissen AM / Edwards AM / Senderowicz AM / Lawrie AM / Martinez AM / Baccino FM / /
TVStation
KSHV / /
Technology
alpha / genomics / php / DNA binding / apoptosis / chemical libraries / treating cancer / drug design / /
[Cell Cycle 4:4, [removed]; April 2005]; ©2005 Landes Bioscience CAK–Cyclin-Dependent Activating Kinase